Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The Cyclin-dependent kinase (CDK) inhibitor abemaciclib, which inhibits Cyclin-dependent kinase 4 (CDK4) and Cyclin-dependent kinase 6 (CDK6), works differently from the two other similar drugs palbociclib and ribociclib. The main differences are in how often you take it and the side effects it causes. Abemaciclib is taken continuously, while the others are taken in breaks. It also tends to cause less of a side effect called neutropenia, which is a low count of a type of white…